Ulcer D014456

Description

A lesion on the surface of the skin or a mucous surface, produced by the sloughing of inflammatory necrotic tissue.   MeSH

Hierarchy View


Approved Indicated Drugs (3)


Organization Involved with Phase 4 Indications (135)

Organization Involved with Phase 3 Indications (177)

Organization Involved with Phase 2 Indications (266)

A2 Healthcare Taiwan Corporation

Abivax S.A.

Academy of Science, Czech Republic

ActoGeniX

Aleris-Hamlet Hospitals Copenhagen

Allergan

Almac Clinical Services LLC

Altermed Co.,Ltd.

Altheus Therapeutics, Inc.

AltruBio

Amgen

AM-Pharma

AnGes, Inc.

Aposcience AG

Applied Molecular Transport

ASKLEP Inc.

Athersys, Inc

Atlantic Health System

Aurealis Oy

AZ Groeninge

Azienda Ospedaliera San Giovanni Addolorata

Azienda Ospedaliera Sant'Andrea, Roma

Bajcsy-Zsilinszky Hospital

Bausch & Lomb

Bayer

Belarusian State Medical University

Biogen

BioLineRx, Ltd.

Boston University

Bridge BioResearch Ltd.

Bridge Biotherapeutics, Inc.

Catalysis SL

Catholic University of Sacred Heart, Rome

Cato Research

Cell Pharma

Centro Medico Militar, Guatemala

Cerimon Pharmaceuticals

Charles University

Charsire Biotechnology Corp.

Chiesi

Chr Hansen

Clinigene International Ltd

Comac Medical

CoMentis

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Cornea Consultants Of Nashville

Cornell University

Covance

CRM Biometrics GmbH

Crohn's and Colitis Canada

Crohn's and Colitis Foundation

Drais Pharmaceuticals, Inc.

Energenesis Biomedical Co., Ltd.

FGK Clinical Research GmbH

First Wave Bio, Inc.

Fortress Biotech

Foundation for Clinical Research in IBD

French National Agency for Research on AIDS and Viral Hepatitis

Friedrich Alexander University

Genentech

GlaxoSmithKline

Gossamer Bio Inc.

Government of Brazil

Government of Russia

Government of Spain

Granzer Regulatory Consulting & Services

Grenoble Alps University

Guizhou Medical University

Gunma University

GW Research

Halmstad University

Hamilton Health Sciences Corporation

Harbor Therapeutics

Harrogate & District NHS Foundation Trust

HCA Retreat Hospital

HealOr

Hemay Pharmaceutical PTY. LTD.

Hofstra University

Holy Stone Healthcare Co., Ltd

Hoosier Cancer Research Network

Humboldt University

Icahn School of Medicine at Mount Sinai

Ilkos Therapeutic Inc.

Immune Pharmaceuticals

Immunic AG

Incyte

inVentiv

Ionis Pharmaceuticals, Inc.

Istituto Dermopatico dell'Immacolata, Roma

Ivy Institute of Stem Cells Co. Ltd

Izun Pharma Ltd

Jinlin University

Joseph Eye Hospital

JP Moulton Charitable Foundation

Kaohsiung Medical University

Karolinska Institute

Karyopharm Therapeutics Inc

Katholieke Universiteit Leuven

Kaunas University

Kitasato University

Klinika Przewodu Pokarmowego Szpital Kliniczny Nr 1 - Lodz - Poland

Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie, Würzburg, Germany

Kobe University

Kolokotrones Family Foundation

Kringle Pharma, Inc.

Kumasi Centre for Collaborative Research

Kuros Biosurgery AG

Kwame Nkrumah University of Science and Technology

Kyoto University

Kyowa Hakko Kirin

Landos Biopharma Inc.

Leading Pharma Llc

Leiden University

Lexicon Pharmaceuticals

LG

Liaocheng People's Hospital

Lipid Therapeutics GmbH

Loma Linda University

Los Angeles Biomedical Research Institute

Luigi Sacco University Hospital

Lund University

L. V. Prasad Eye Institute

Lycera Corp.

Lynch Biologics LLC

Medelis Inc.

MedImmune

MediWound Ltd

Merck Serono

Mesoblast, Inc.

Microbio Co Ltd

MitoQ Ltd

Monash University

NanoSHIFT LLC

National Academy of Sciences of Belarus

National Center for Research Resources (NCRR)

National Institute of Allergy and Infectious Diseases (NIAID)

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

National Institutes of Health (NIH)

Natrogen Therapeutics International, Inc

Newcastle University

NHS Lothian

Nitric BioTherapeutics, Inc

Northwell Health

Novartis

Ocunexus

Ology Bioservices

Oncostellae S.L

Orebro University

Ore Pharmaceuticals, Inc.

Orion Corporation

Osakidetza

OXO Chemie

Palau Pharma S.A.

Paloma Pharmaceuticals, Inc.

PharmaKing

Photopharmica

PLx Pharma

PPM Services S.A.

Premier Research Group

Prolong Pharmaceuticals

Protagonist Therapeutics

Protalix

PurGenesis Technologies Inc.

Qingdao University

QualitecFarma

Qu Biologics

Queen Elizabeth Hospital NHS Foundation Trust

Regenera Pharma Ltd

RegeneRx Biopharmaceuticals, Inc.

Reistone Biopharma Company Limited

Remedor Biomed Ltd

Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan

ReveraGen BioPharma, Inc.

Rheacell GmbH & Co. KG

Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust

Royan Institute

Royer Biomedical, Inc.

Samodzielny Publiczny Szpital

Sanofi

Santa Barbara Cottage Hospital

SCRI Development Innovations

SerenaGroup, Inc.

Seres Therapeutics

Shinshu University

Shiraz University

Sintesi Research Srl

Skingenix, Inc.

Society for Pediatric Dermatology

Sofferenza Hospital

Srinakharinwirot University

State University of Maringá

Sterna Biologicals GmbH & Co. KG

Sublimity Therapeutics

Sun Yat-Sen University

Sykehuset Innlandet HF

TauTona Group

Technical University of Denmark

Telsar Pharma Inc.

The Cleveland Clinic

The Eli and Edythe Broad Foundation

The University of Texas, Dallas

Third Military Medical University

Thrasher Research Fund

TICEBA GmbH

Topivert Pharma Ltd

Tower Multispecialty Medical Group

Tower Outpatient Surgical Center

TransCom Global Ltd

Translational Research Informatics Center, Kobe, Hyogo, Japan

Transwell Biotech Co., Ltd.

Turning Point Therapeutics

Universidad Autónoma de Bucaramanga

Universitaetsklinikum Schleswig-Holstein

Universitair Ziekenhuis Gent

University Hospital of North Norway

University of Alberta

University of Antwerp

University of Arizona

University of Bath

University of Bergen

University of Bonn

University of British Columbia

University of California, Los Angeles

University of California, San Diego

University of Duesseldorf

University of Edinburgh

University of Erlangen-Nuremberg

University of Exeter

University of Franche-Comté

University of Grenoble

University of Hull

University of Illinois at Chicago

University of Jordan

University of Leeds

University of Louisville

University of Manchester

University of Maryland

University of Minnesota

University of Naples Frederico II

University of Oslo

University of Ottawa

University of Picardie Jules Verne

University of Roma La Sapienza

University of Rome Tor Vergata

University of Saskatchewan

University of Southern California

University of Tehran

University of Tennessee

University of Texas at Houston

University of the Philippines

University of Toronto

University of Vermont

University of Warwick

University of York

Uppsala University

US Biotest

Utrecht University

Vancouver Island Health Authority

VBL

Vigilex BV

Vilnius University

Virginia Mason Medical Center

Western Norway Regional Health Authority

Wojewodzki Szpital

Wrightington, Wigan and Leigh NHS Foundation Trust

Xijing Hospital

Organization Involved with Other Experimental Indications (57)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.